Man Group PLC Mirum Pharmaceuticals, Inc. Transaction History
Man Group PLC
- $35.6 Billion
- Q4 2024
A detailed history of Man Group PLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Man Group PLC holds 6,989 shares of MIRM stock, worth $364,616. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,989Holding current value
$364,616% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$343 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$239 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$169 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$146 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$136 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.92B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...